Nautilus Biotechnology Inc. (NAUT) NASDAQ
$2.81 (0.06) (-2.09%)
Market Cap: $359.51M
As of 05/16/24 09:30 AM EDT. Market open.
Nautilus Biotechnology Inc. (NAUT)
NASDAQ
$2.81
(0.06) (-2.09%)
Market Cap: $359.51M
As of 05/16/24 09:30 AM EDT. Market open.
Add to Portfolio
born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
170
URL
Address
.
PRICE CHART FOR NAUTILUS BIOTECHNOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.81
Previous Close
$2.87
Days Range
$2.87 - $2.92
52 week range
$2.27 - $4.65
Volume
4,893
Avg. Volume (30 days)
66,935
Market Cap
$359.51M
Dividend Yield
-
P/E
-
Shares Outstanding
125,265,015
Open
$2.81
Previous Close
$2.87
Days Range
$2.87 - $2.92
52 week range
$2.27 - $4.65
Volume
4,893
Avg. Volume (30 days)
66,935
Market Cap
$359.51M
Dividend Yield
-
P/E
-
Shares Outstanding
125,265,015
FINANCIAL STATEMENTS FOR NAUTILUS BIOTECHNOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NAUTILUS BIOTECHNOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Patel Sujal M | CEO, President, and Secretary | Mar 11, 2024 | Buy | $2.84 | 12,044 | 34,216 | 10,064,488 | Mar 11, 2024, 08:21 PM |
| Patel Sujal M | CEO, President, and Secretary | Mar 08, 2024 | Buy | $2.99 | 2,430 | 7,262 | 10,052,444 | Mar 11, 2024, 08:21 PM |
| Patel Sujal M | CEO, President, and Secretary | Mar 06, 2024 | Buy | $2.70 | 9,267 | 25,034 | 10,031,160 | Mar 07, 2024, 07:06 PM |
| Patel Sujal M | CEO, President, and Secretary | Mar 05, 2024 | Buy | $2.65 | 7,405 | 19,597 | 10,021,893 | Mar 07, 2024, 07:06 PM |
| Patel Sujal M | CEO, President, and Secretary | Mar 07, 2024 | Buy | $2.89 | 18,854 | 54,424 | 10,050,014 | Mar 07, 2024, 07:06 PM |
| Sankar Subramanian | Senior VP, Product Development | Sep 27, 2022 | Buy | $2.03 | 5,000 | 10,149 | 91,250 | Sep 28, 2022, 04:01 PM |
| Sankar Subramanian | Senior VP, Product Development | Sep 26, 2022 | Buy | $2.03 | 10,000 | 20,250 | 86,250 | Sep 28, 2022, 04:01 PM |
| Weld Gwen E | Chief People Officer | Sep 23, 2022 | Buy | $2.03 | 30,000 | 60,765 | 30,000 | Sep 26, 2022, 09:26 PM |
| Sankar Subramanian | Senior VP, Product Development | Sep 15, 2022 | Buy | $2.19 | 40,000 | 87,752 | 40,000 | Sep 19, 2022, 05:50 PM |
| Sankar Subramanian | Senior VP, Product Development | Sep 16, 2022 | Buy | $2.16 | 35,000 | 75,446 | 75,000 | Sep 19, 2022, 05:50 PM |
| Mowry Anna | CFO and Treasurer | Aug 19, 2022 | Buy | $2.30 | 17,500 | 40,218 | 56,750 | Aug 22, 2022, 07:40 PM |
| Murphy Matthew B. | General Counsel | Aug 15, 2022 | Buy | $2.84 | 7,500 | 21,308 | 54,140 | Aug 16, 2022, 08:19 PM |
| Murphy Matthew B. | General Counsel | Aug 12, 2022 | Buy | $2.85 | 2,500 | 7,125 | 46,640 | Aug 16, 2022, 08:19 PM |
| Patel Sujal M | CEO, President, and Secretary | Aug 08, 2022 | Buy | $2.93 | 8,346 | 24,444 | 10,014,488 | Aug 08, 2022, 07:48 PM |
| Patel Sujal M | CEO, President, and Secretary | Aug 05, 2022 | Buy | $2.92 | 41,654 | 121,646 | 10,006,142 | Aug 08, 2022, 07:48 PM |
| Mowry Anna | CFO and Treasurer | Jun 27, 2022 | Buy | $2.75 | 5,500 | 15,124 | 39,250 | Jun 28, 2022, 06:17 PM |
| Murphy Matthew B. | General Counsel | May 12, 2022 | Option Exercise | $3.28 | 10,000 | 32,800 | 44,140 | May 13, 2022, 05:09 PM |
| Patel Sujal M | CEO, President, and Secretary | May 09, 2022 | Buy | $3.96 | 50,000 | 198,000 | 9,964,488 | May 10, 2022, 08:28 PM |
| Patel Sujal M | CEO, President, and Secretary | Mar 04, 2022 | Option Exercise | $10.00 | 100 | 1,000 | 9,914,488 | Mar 04, 2022, 05:39 PM |
| Patel Sujal M | CEO, President, and Secretary | Mar 03, 2022 | Buy | $3.60 | 50,000 | 179,890 | 9,914,388 | Mar 04, 2022, 05:39 PM |
| PERCEPTIVE ADVISORS LLC | Director | Dec 08, 2021 | Buy | $5.36 | 200,000 | 1,072,000 | 9,111,151 | Dec 10, 2021, 04:05 PM |
| Patel Sujal M | CEO, President, and Secretary | Nov 30, 2021 | Buy | $4.72 | 161,978 | 764,779 | 9,776,366 | Dec 02, 2021, 08:49 AM |
| Patel Sujal M | CEO, President, and Secretary | Dec 01, 2021 | Buy | $4.73 | 88,022 | 416,397 | 9,864,388 | Dec 02, 2021, 08:49 AM |
| Posard Matthew L. | Director | Dec 01, 2021 | Buy | $4.47 | 30,000 | 134,105 | 50,000 | Dec 01, 2021, 09:41 PM |
| Posard Matthew L. | Director | Nov 30, 2021 | Buy | $4.57 | 20,000 | 91,400 | 20,000 | Dec 01, 2021, 09:41 PM |
| Mowry Anna | CFO and Treasurer | Nov 24, 2021 | Buy | $4.58 | 15,000 | 68,633 | 32,500 | Nov 24, 2021, 05:12 PM |
| McIlwain Matthew S | Director | Nov 15, 2021 | Buy | $5.30 | 100,000 | 529,890 | 459,075 | Nov 17, 2021, 08:19 PM |
| McIlwain Matthew S | Director | Aug 25, 2021 | Buy | $7.74 | 11,693 | 90,458 | 347,366 | Aug 26, 2021, 07:29 PM |
| McIlwain Matthew S | Director | Aug 24, 2021 | Buy | $7.68 | 13,568 | 104,269 | 335,673 | Aug 26, 2021, 07:29 PM |
| McIlwain Matthew S | Director | Aug 26, 2021 | Buy | $7.71 | 11,709 | 90,314 | 359,075 | Aug 26, 2021, 07:29 PM |
| Mowry Anna | CFO and Treasurer | Aug 12, 2021 | Buy | $7.71 | 17,500 | 134,925 | 17,500 | Aug 16, 2021, 05:12 PM |
| Murphy Matthew B. | General Counsel | Aug 13, 2021 | Buy | $7.56 | 5,000 | 37,806 | 34,140 | Aug 13, 2021, 09:01 PM |
| PERCEPTIVE ADVISORS LLC | Former Director | Jun 09, 2021 | Buy | $10.00 | 5,500,000 | 55,000,000 | 5,997,038 | Jun 11, 2021, 05:45 PM |
| PERCEPTIVE ADVISORS LLC | Former Director | May 24, 2021 | Buy | $10.05 | 7,063 | 70,983 | 497,038 | Jun 11, 2021, 05:45 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jun 03, 2021 | Buy | $10.05 | 330,050 | 3,317,003 | 489,975 | Jun 03, 2021, 06:55 PM |
| PERCEPTIVE ADVISORS LLC | Director | May 20, 2021 | Buy | $10.05 | 159,925 | 1,607,246 | 159,925 | May 24, 2021, 06:49 PM |
| ARYA Sciences Holdings III | 10% Owner | Aug 11, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Aug 11, 2020, 08:48 PM |
| Stone Adam Leo | Chief Executive Officer | Aug 11, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Aug 11, 2020, 08:43 PM |
| ALTMAN MICHAEL SETH | Chief Financial Officer | Aug 11, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Aug 11, 2020, 08:38 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Patel Sujal M | CEO, President, and Secretary | 03/11/2024 | 34,216 |
| Patel Sujal M | CEO, President, and Secretary | 03/08/2024 | 7,262 |
| Patel Sujal M | CEO, President, and Secretary | 03/06/2024 | 25,034 |
| Patel Sujal M | CEO, President, and Secretary | 03/05/2024 | 19,597 |
| Patel Sujal M | CEO, President, and Secretary | 03/07/2024 | 54,424 |
| Sankar Subramanian | Senior VP, Product Development | 09/27/2022 | 10,149 |
| Sankar Subramanian | Senior VP, Product Development | 09/26/2022 | 20,250 |
| Weld Gwen E | Chief People Officer | 09/23/2022 | 60,765 |
| Sankar Subramanian | Senior VP, Product Development | 09/15/2022 | 87,752 |
| Sankar Subramanian | Senior VP, Product Development | 09/16/2022 | 75,446 |
| Mowry Anna | CFO and Treasurer | 08/19/2022 | 40,218 |
| Murphy Matthew B. | General Counsel | 08/15/2022 | 21,308 |
| Murphy Matthew B. | General Counsel | 08/12/2022 | 7,125 |
| Patel Sujal M | CEO, President, and Secretary | 08/08/2022 | 24,444 |
| Patel Sujal M | CEO, President, and Secretary | 08/05/2022 | 121,646 |
| Mowry Anna | CFO and Treasurer | 06/27/2022 | 15,124 |
| Murphy Matthew B. | General Counsel | 05/12/2022 | 32,800 |
| Patel Sujal M | CEO, President, and Secretary | 05/09/2022 | 198,000 |
| Patel Sujal M | CEO, President, and Secretary | 03/04/2022 | 1,000 |
| Patel Sujal M | CEO, President, and Secretary | 03/03/2022 | 179,890 |
| PERCEPTIVE ADVISORS LLC | Director | 12/08/2021 | 1,072,000 |
| Patel Sujal M | CEO, President, and Secretary | 11/30/2021 | 764,779 |
| Patel Sujal M | CEO, President, and Secretary | 12/01/2021 | 416,397 |
| Posard Matthew L. | Director | 12/01/2021 | 134,105 |
| Posard Matthew L. | Director | 11/30/2021 | 91,400 |
| Mowry Anna | CFO and Treasurer | 11/24/2021 | 68,633 |
| McIlwain Matthew S | Director | 11/15/2021 | 529,890 |
| McIlwain Matthew S | Director | 08/25/2021 | 90,458 |
| McIlwain Matthew S | Director | 08/24/2021 | 104,269 |
| McIlwain Matthew S | Director | 08/26/2021 | 90,314 |
| Mowry Anna | CFO and Treasurer | 08/12/2021 | 134,925 |
| Murphy Matthew B. | General Counsel | 08/13/2021 | 37,806 |
| PERCEPTIVE ADVISORS LLC | Former Director | 06/09/2021 | 55,000,000 |
| PERCEPTIVE ADVISORS LLC | Former Director | 05/24/2021 | 70,983 |
| PERCEPTIVE ADVISORS LLC | Director | 06/03/2021 | 3,317,003 |
| PERCEPTIVE ADVISORS LLC | Director | 05/20/2021 | 1,607,246 |
| ARYA Sciences Holdings III | 10% Owner | 08/11/2020 | 4,990,000 |
| Stone Adam Leo | Chief Executive Officer | 08/11/2020 | 4,990,000 |
| ALTMAN MICHAEL SETH | Chief Financial Officer | 08/11/2020 | 4,990,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NAUTILUS BIOTECHNOLOGY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,731,804 | 0.00026% | -4.16% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,106,951 | 0.0003% | 3.91% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 126,000 | 0.00058% | 7.97% | Other |
CHANGE IN SHARES OUTSTANDING FOR NAUTILUS BIOTECHNOLOGY INC
STOCK BUYBACKS FOR NAUTILUS BIOTECHNOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.12%
1Q
09/30/2023
0.16%
2Q
06/30/2023
0.43%
3Q
03/31/2023
0.44%
4Q
12/31/2022
0.28%
5Q
09/30/2022
0.39%
6Q
06/30/2022
0.52%
7Q
03/31/2022
0.58%
8Q
12/31/2021
48.15%
9Q
09/30/2021
0.82%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NAUTILUS BIOTECHNOLOGY INC
LOADING...